428 related articles for article (PubMed ID: 18931014)
1. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
2. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
3. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
4. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
[TBL] [Abstract][Full Text] [Related]
5. Chorea secondary to striatal encephalitis due to anti-CV2/CRMP5 antibodies. Case description and review of the literature.
Crespo-Burillo JA; Hernando-Quintana N; Ruiz-Palomino P; Martín-Martínez J
Neurologia; 2015 Sep; 30(7):451-3. PubMed ID: 24332782
[No Abstract] [Full Text] [Related]
6. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease.
Qvale TH; Storstein A; Mazengia K; Eagan TM; Bakke PS; Vedeler CA
Respirology; 2014 Jul; 19(5):730-4. PubMed ID: 24697843
[TBL] [Abstract][Full Text] [Related]
8. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.
Yan J; Chen Z; Liang Y; Yang H; Cao L; Zhou Y; Zhao Y; Zhang Y
J Int Med Res; 2020 Dec; 48(12):300060520974466. PubMed ID: 33305627
[TBL] [Abstract][Full Text] [Related]
9. [Neuropathy associated with paraneoplastic neurological syndrome].
Mitsui Y; Kusunoki S
Brain Nerve; 2010 Apr; 62(4):387-93. PubMed ID: 20420179
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent.
Ibrahim Ismail I; K John J; Ibrahim M; Al-Hashel JY
Case Rep Neurol; 2020; 12(1):50-55. PubMed ID: 32110228
[TBL] [Abstract][Full Text] [Related]
11. Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer.
Hiasa Y; Kunishige M; Mitsui T; Kondo S; Kuriwaka R; Shigekiyo S; Kanematsu T; Satake N; Bando Y; Kondo A; Endo I; Oshima Y; Matsumoto T
Clin Neurol Neurosurg; 2003 Dec; 106(1):47-9. PubMed ID: 14643918
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
13. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
14. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.
Graus F; Keime-Guibert F; Reñe R; Benyahia B; Ribalta T; Ascaso C; Escaramis G; Delattre JY
Brain; 2001 Jun; 124(Pt 6):1138-48. PubMed ID: 11353730
[TBL] [Abstract][Full Text] [Related]
15. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
16. [Limbic encephalitis with antibodies against intracellular antigens].
Morita A; Kamei S
Brain Nerve; 2010 Apr; 62(4):347-55. PubMed ID: 20420174
[TBL] [Abstract][Full Text] [Related]
17. Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
Uysal SP; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Conway DS; Ontaneda D; Morren JA; Kunchok A
Ann Clin Transl Neurol; 2024 Mar; 11(3):710-718. PubMed ID: 38251800
[TBL] [Abstract][Full Text] [Related]
18. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature.
Jarius S; Wandinger KP; Borowski K; Stoecker W; Wildemann B
Clin Neurol Neurosurg; 2012 May; 114(4):331-5. PubMed ID: 22138095
[TBL] [Abstract][Full Text] [Related]
20. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
